Details for 2017857495
Up to date per 01.04.2026
Actions
Details for 2017857495
Granted/Registered
European Patent
07.08.2019 A
10.08.2022 B1
30.09.2016
US
201662402119 P
A61K 31/437 20060101AFI20200325BHEP
Owner
Salix Pharmaceuticals, Inc.400 Somerset Corporate Boulevard Bridgewater, NJ 08807US
Representative
Representative
Babeluk Patentanwälte GmbHFlorianigasse 26/31080 WienAT
Inventor
GOLDEN, Pam5 Fontana Ct. Durham, NC 27713US
KABIR, Mohammed A.703 Unison Ct. Cary, NC 27519US
Information about Fees